摘要 |
This invention relates to compounds of the formula wherein X is N and Y is S or O; or X is S or O and Y is N; R<SUP>1 </SUP>is hydrogen or C<SUB>1-7</SUB>-alkyl; R<SUP>2 </SUP>and R<SUP>3 </SUP>independently from each other are selected from the group consisting of hydrogen, C<SUB>1-7</SUB>-alkyl and C<SUB>1-7</SUB>-alkoxy; R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, and R<SUP>7 </SUP>independently from each other are selected from the group consisting of hydrogen, C<SUB>1-7</SUB>-alkyl, C<SUB>3-7</SUB>-cycloalkyl, halogen, C<SUB>1-7</SUB>-alkoxy, C<SUB>1-7</SUB>-alkyl-C<SUB>1-7</SUB>-alkoxy-C<SUB>1-7</SUB>-alkyl, C<SUB>2-7</SUB>-alkenyl, C<SUB>2-7</SUB>-alkinyl, fluoro-C<SUB>1-7</SUB>-alkyl and cyano; R<SUP>8 </SUP>is selected from the group consisting of hydrogen, C<SUB>1-7</SUB>-alkyl, C<SUB>3-7</SUB>-cycloalkyl and fluoro-C<SUB>1-7</SUB>-alkyl; R<SUP>9 </SUP>is selected from the group consisting of hydrogen, C<SUB>1-7</SUB>-alkyl, C<SUB>2-7</SUB>-alkinyl, C<SUB>3-7</SUB>-cycloalkyl and fluoro-C<SUB>1-7</SUB>-alkyl; R<SUP>10 </SUP>is selected from the group consisting of hydrogen, C<SUB>1-7</SUB>-alkyl, C<SUB>2-7</SUB>-alkinyl, C<SUB>3-7</SUB>-cycloalkyl and fluoro-C<SUB>1-7</SUB>-alkyl; R<SUP>11 </SUP>is aryl or heteroaryl; N is 0, 1 or 2; and all enantiomers and pharmaceutically acceptable salts and/or esters thereof and their use as PPAR activators. |
申请人 |
F. HOFFMANN-LA ROCHE AG. |
发明人 |
JEAN ACKERMANN,JOHANNES AEBI,ALFRED BINGGELI,UWE GRETHER, GEORGES HIRTH,BERND KUHN,HANS-PETER MAERKI,MARKUS MEYER |